Together, our studies provide the genetic evidences that TMEM43 S358L mutation contributes to the development of ARVD pathogenesis, and reveal a novel mechanism by which TMEM43 S358L mutation induces the development of ARVD. The gene discussed is TMEM43; the disease is arrhythmogenic right ventricular cardiomyopathy.